Repeat transcatheter aortic valve replacement (TAVR) for the treatment of failed TAVR appears to be safe, with 100% procedural success and overall low rates of all-cause mortality and stroke, at 1-year follow-up, according to study results presented Saturday at the TCT Connect virtual conference.